Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

BACKGROUND: Correlates of protection could help to assess the extent to which a person is protected from SARS-CoV-2 infection after vaccination (so-called breakthrough infection). We aimed to clarify associations of antibody and T-cell responses after vaccination against COVID-19 with risk of a SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Seekircher, Lisa, Bánki, Zoltán, Kimpel, Janine, Rössler, Annika, Schäfer, Helena, Falkensammer, Barbara, Bante, David, Forer, Lukas, Schönherr, Sebastian, Harthaller, Teresa, Sacher, Magdalena, Ower, Cornelia, Tschiderer, Lena, Ulmer, Hanno, Krammer, Florian, von Laer, Dorothee, Borena, Wegene, Willeit, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284585/
https://www.ncbi.nlm.nih.gov/pubmed/37354911
http://dx.doi.org/10.1016/S2666-5247(23)00107-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284585/
https://www.ncbi.nlm.nih.gov/pubmed/37354911
http://dx.doi.org/10.1016/S2666-5247(23)00107-6

Ejemplares similares